Pressrelease – Lund, April 23, 2026 – Monthly investor meeting on the 29th of April, 2026

Hamlet Biopharma
|
April 23, 2026
An innovative pharmaceutical company with a broad and strong portfolio of projects for the treatment of cancer and infections.
Hamlet BioPharma AB
Klinikgatan 32
SE-222 42 Lund
info@hamletbiopharma.com
Org. no. 556568-8958
Subscribe to receive
Pressreleases and Newsletters
© 2026
Hamlet BioPharma.